PCG Membership

Member Institutions

Beaumont Health

3601 W. 13 Mile Rd., Royal Oak, MI 48073

California Protons Cancer Therapy Center
9730 Summers Ridge Rd, San Diego, CA 92121

Delray Medical Center
5352 Linton Boulevard, Delray Beach, FL 33484

Hampton University Proton Therapy Institute

40 Enterprise Parkway, Hampton, VA 23666

Maryland Proton Center

850 West Baltimore Street, Baltimore, MD 21201

Mayo Clinic

200 First Street SW, Rochester, MN 55905

Mayo Clinic

5777 East Mayo Boulevard, Phoenix, AZ, 85054

Miami Cancer Institute
8900 North Kendall Drive, Miami, FL 33176

New York Proton Center
225 East 126th Street, New York, NY 10035

Northwestern Medicine Chicago Proton Center

4455 Weaver Parkway, Warrenville, IL 60555

Procure Proton Therapy Center – New Jersey
103 Cedar Grove Lane, Somerset, New Jersey 08873

Oklahoma Proton Center – Oklahoma City

5901 W Memorial Road, Oklahoma City, OK 73142

Seattle Cancer Care Alliance Proton Therapy Center

1570 N 115th Street, Seattle, WA 98133

The University of Alabama at Birmingham (UAB)

1720 2nd Ave South, Birmingham, AL 35294

The University of Florida Proton Therapy Institute

2015 North Jefferson Street, Jacksonville, FL 32206

Willis-Knighton Proton Therapy Center

2600 Kings Highway, Shreveport, LA 71103

Membership Information

Full Membership:

Full membership with PCG includes access to the PCG registry (REG001-09) as well as ALL of the PCG trials/protocols listed here.

REGISTRY

PCG – REG001-09

Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy

BREAST

PCG – BRE007-12

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

PCG – BRE008-12 (Closed to enrollment)

Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients with Stage II/III, Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation with Lymph Node Irradiation

LUNG

PCG – LUN005-12 (Closed to enrollment)

A Phase I/II Study of Hypo-fractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

PROSTATE

PCG – GU002-10

A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation with Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate

PCG – GU003-10

Phase III Study of Mildly Hypo-fractionated Image Guided Proton Beam Radiation Therapy with or without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate

PCG – GU010-18

Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy

PANCREAS

PCG – PAN009-18

A Phase III Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma

Registry Membership:

A Registry membership with PCG includes access to the PCG registry (REG001-09) only.

REGISTRY

PCG – REG001-09

Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy

Single Study Membership:

PCG offers membership on a per trial/protocol basis. Sites may choose to participate in any combination of the PCG trials/protocols listed below (the registry trial is excluded from this type of membership level).

BREAST

PCG – BRE007-12

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

PCG – BRE008-12 (Closed to enrollment)

Phase II Study of Postoperative, Cardiac-Sparing Proton Radiotherapy for Patients with Stage II/III, Loco-Regional, Non-Metastatic Breast Cancer Requiring Whole Breast or Chest Wall Irradiation with Lymph Node Irradiation

LUNG

PCG – LUN005-12 (Closed to enrollment)

A Phase I/II Study of Hypo-fractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

PROSTATE

PCG – GU002-10

A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation with Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate

PCG – GU003-10

Phase III Study of Mildly Hypo-fractionated Image Guided Proton Beam Radiation Therapy with or without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate

PCG – GU010-18

Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy

PANCREAS

PCG – PAN009-18

A Phase III Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma

For more information about PCG membership,
contact Jillian Plochocki-Smallwood at [email protected]